Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Liver Cancer|June 20, 2017
The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial ChemoembolizationTadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, et al.
Oncology|November 20, 2015
Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, et al.
Cancers|July 10, 2019
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter StudyKazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2017
Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting AntiviralsMasashi Kono, Naoshi Nishida, Satoru Hagiwara, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2017
Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2Tadaaki Arizumi, Tomohiro Minami, Hirokazu Chishina, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2017
Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2Tadaaki Arizumi, Tomohiro Minami, Hirokazu Chishina, et al.
Cancers|August 3, 2019
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept StudyMasatoshi Kudo, Kazuomi Ueshima, Stephan Chan, et al.
Oncology|December 19, 2016
Malignant Transformation of Hepatocellular AdenomaWing Yee Kwok, Satoru Hagiwara, Naoshi Nishida, et al.
Clinical and Molecular Hepatology|March 11, 2025
Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling PathwayTomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, et al.
Pageof 6